Articles
Found - the 37th type of chemical reaction and it's low-temp
Until now, only 36 basic types of chemical reactions have been identified. But a 37th type has just been added to the list. [ + ]
ResMed completes recruitment for heart failure trial
ResMed (ASX:RMD) has signed up all 1325 patients for what it is billing as the world's largest study of sleep-disordered breathing therapy in at-risk heart failure patients. [ + ]
Seagrass provides blue carbon reserve
As well as being a favourite feeding ground for dugongs and sea turtles, seagrass meadows may be a major carbon sink for the planet. [ + ]
2013 Eureka Prize winners
From diamonds that light up the inside of cells to broody male weedy sea dragons, this year's Australian Museum Eureka Prizes recognise some of the great work and great people in Australian science. [ + ]
GI Dynamics extends Australian reach of EndoBarrier
GI Dynamics (ASX:GID) said five new centres in Australian capital cities have agreed to offer EndoBarrier as a treatment option for type 2 diabetes and obesity. [ + ]
Clinuvel posts follow-up data from vitiligo trial
During a recent trial, Clinuvel's Scenesse (ASX:CUV) was able to improve repigmentation in patients undergoing NB-UVB therapy for vitiligo, and to help sustain the effect. [ + ]
Why does jet-lag recovery lag?
Researchers at the University of Oxford, University of Notre Dame and F Hoffmann-La Roche have identified a mechanism that limits the ability of the body clock to adjust to changes in patterns of light and dark. This in turn reveals why the body is so slow to recover from jet lag. [ + ]
Uncovering the best cab sav clones
The local wine industry and consumers will both benefit following research to identify differences in the top cabernet sauvignon grape clones. [ + ]
Breeding sorghum to feed the world
Whole genome resequencing reveals sorghum contains much more genetic variation than previously realised. [ + ]
Why taller people are smarter
It hardly seems fair but people who are attractive because of one trait tend to have other attractive traits as well. [ + ]
FDA knocks back QRxPharma's MoxDuo again
QRxPharma (ASX:QRL) will need to resubmit its FDA application for MoxDuo IR again, after the regulator issued a second Complete Response Letter. [ + ]
Allied Healthcare gets CE Mark for CardioCel
After securing regulatory approval, Allied Healthcare (ASX:AHZ) now expects to start selling its CardioCel heart patch in Europe in calendar Q4. [ + ]
University of Adelaide ‘braggs’ about transdisciplinary facility
In July 2013, following the award of $29 million from the Education Investment Fund, ‘The Braggs’ was officially opened. Named after University of Adelaide alumni Sir William Henry Bragg and his son, Sir William Lawrence Bragg, the $100 million building is the home of the Institute for Photonics and Advanced Sensing (IPAS). [ + ]
Hypertension drugs increase the effect of chemo in childhood cancer
Beta-blockers are traditionally used in the treatment of high blood pressure, but researchers at the Children’s Cancer Institute Australia (CCIA) have found that they can also increase the effectiveness of chemotherapy in treating aggressive childhood cancers such as neuroblastoma. [ + ]
Ascend gears up for cancer immunotherapy trials
Ascend Biopharmaceuticals CEO Clement Leong details the company’s plans for Australian clinical trials of its key products, a cancer vaccine and an oncolytic virus. [ + ]
